The U.S. Department of Justice announced that Walmart has agreed to pay $50 million to resolve allegations that it illegally issued opioid prescriptions.

The company also signed a memorandum of agreement with the Drug Enforcement Administration to clarify its future obligations in dispensing controlled substances.